302 related articles for article (PubMed ID: 31054580)
21. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
22. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
Yoshida-Moriguchi T; Campbell KP
Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
[TBL] [Abstract][Full Text] [Related]
23. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
24.
Yonekawa T; Rauckhorst AJ; El-Hattab S; Cuellar MA; Venzke D; Anderson ME; Okuma H; Pewa AD; Taylor EB; Campbell KP
Sci Adv; 2022 May; 8(21):eabn0379. PubMed ID: 35613260
[TBL] [Abstract][Full Text] [Related]
25. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
26. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
Balci-Hayta B; Talim B; Kale G; Dincer P
BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase.
Katz M; Diskin R
PLoS One; 2022; 17(12):e0278713. PubMed ID: 36512577
[TBL] [Abstract][Full Text] [Related]
28. Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.
Shelton GD; Minor KM; Guo LT; Friedenberg SG; Cullen JN; Hord JM; Venzke D; Anderson ME; Devereaux M; Prouty SJ; Handelman C; Campbell KP; Mickelson JR
Neuromuscul Disord; 2021 Nov; 31(11):1169-1178. PubMed ID: 34654610
[TBL] [Abstract][Full Text] [Related]
29. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
30. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
31. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
[TBL] [Abstract][Full Text] [Related]
33. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
Toda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
[TBL] [Abstract][Full Text] [Related]
34. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
[TBL] [Abstract][Full Text] [Related]
35. Identification of Matriglycan by Dual Exoglycosidase Digestion of α-Dystroglycan.
Chandel I; Campbell KP
Bio Protoc; 2023 Sep; 13(18):e4827. PubMed ID: 37753476
[No Abstract] [Full Text] [Related]
36. Lassa Fever Virus Binds Matriglycan-A Polymer of Alternating Xylose and Glucuronate-On α-Dystroglycan.
Joseph S; Campbell KP
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578260
[TBL] [Abstract][Full Text] [Related]
37. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
[TBL] [Abstract][Full Text] [Related]
38. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
39. Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle.
Brockington M; Torelli S; Sharp PS; Liu K; Cirak S; Brown SC; Wells DJ; Muntoni F
PLoS One; 2010 Dec; 5(12):e14434. PubMed ID: 21203384
[TBL] [Abstract][Full Text] [Related]
40. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
